Evolocumab 相關新聞

← 返回新聞總覽

---

Evolocumab 目前有 0 則相關新聞報導，預測適應症 10 個。

本頁整合 Evolocumab 的 AI 預測適應症與最新健康新聞，橘色標示的適應症表示近期有相關新聞報導。

藥物資訊

• 證據等級：L5
• 預測適應症（10 個）：
  • Symptomatic hemophilia in female carriers | 99.82% | Very low | No PCSK9–coagulation factor link（99.0%）
  • Familial apolipoprotein C-II deficiency | 99.50% | Low | TG/VLDL axis, not LDL axis（99.0%）
  • Thrombocytopenic purpura | 99.42% | Very low | Autoimmune/TMA, not lipid-mediated（99.0%）
  • Factor XI deficiency | 99.29% | Very low | Intrinsic coagulation pathway defect（99.0%）
  • Hemophilia A with vascular abnormality | 99.22% | Indirect only | LDL lowering may reduce CV risk in this subgroup — but this is an extension of existing indication, not true repurposing（99.0%）
  • Disease of catalytic activity | 99.08% | None (ontological artifact) | PCSK9 is a serine protease; KG mis-links（99.0%）
  • Hemorrhagic disease of newborn | 98.89% | Very low | Vitamin K-dependent clotting, unrelated to PCSK9（99.0%）
  • X-linked ichthyosis (without STS deficiency) | 98.84% | Very low | Cholesterol sulfate pathway ≠ systemic LDL-R regulation（99.0%）
  • Inherited thrombophilia | 98.82% | Low–moderate (theoretical) | Highest relative biological rationale among the 10; high LDL can potentiate thrombotic risk, but no Evolocumab-specific trial evidence（99.0%）
  • Disorder of vitamins/cofactors metabolism | 98.80% | Very low (ontological) | LDL carries fat-soluble vitamins — highly speculative（99.0%）

查看完整藥物報告 →

相關新聞（0 則）

目前沒有相關新聞報導。當有新聞提到此藥物時，系統會自動收集並顯示在這裡。

免責聲明：本頁新聞由系統自動收集，僅供研究參考，不構成醫療建議。